1-8 of 8
David E. Gerber
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Modernizing Clinical Trial Eligibility Criteria: Recommendations of the ASCO-Friends of Cancer Research Laboratory Reference Ranges and Testing Intervals Work Group

Alexander I. Spira, Mark D. Stewart, Suzanne Jones, Elaine Chang, Anitra Fielding, Nicole Richie, Laura S. Wood, Michael A. Thompson, Lee Jones, Abhilasha Nair, Brandon A. Mahal, David E. Gerber
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (9): 2416–2423.
DOI: https://doi.org/10.1158/1078-0432.CCR-20-3853
Published: 01 May 2021
View article
PDF
Includes: Supplementary data
Journal Articles

Concentration-dependent Early Antivascular and Antitumor Effects of Itraconazole in Non–Small Cell Lung Cancer

David E. Gerber, William C. Putnam, Farjana J. Fattah, Kemp H. Kernstine, Rolf A. Brekken, Ivan Pedrosa, Rachael Skelton, Jessica M. Saltarski, Robert E. Lenkinski, Richard D. Leff, Chul Ahn, Chyndhri Padmanabhan, Vaidehi Chembukar, Sahba Kasiri, Raja Reddy Kallem, Indhumathy Subramaniyan, Qing Yuan, Quyen N. Do, Yin Xi, Scott I. Reznik, Lorraine Pelosof, Brandon Faubert, Ralph J. DeBerardinis, James Kim
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (22): 6017–6027.
DOI: https://doi.org/10.1158/1078-0432.CCR-20-1916
Published: 13 November 2020
View article
PDF
Includes: Supplementary data
Journal Articles

DC-HIL/Gpnmb Is a Negative Regulator of Tumor Response to Immune Checkpoint Inhibitors

Jin-Sung Chung, Vijay Ramani, Masato Kobayashi, Farjana Fattah, Vinita Popat, Song Zhang, Ponciano D. Cruz, Jr, David E. Gerber, Kiyoshi Ariizumi
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (6): 1449–1459.
DOI: https://doi.org/10.1158/1078-0432.CCR-19-2360
Published: 13 March 2020
View article
PDF
Includes: Supplementary data
Journal Articles

Phase Ia Study of Anti-NaPi2b Antibody–Drug Conjugate Lifastuzumab Vedotin DNIB0600A in Patients with Non–Small Cell Lung Cancer and Platinum-Resistant Ovarian Cancer

David E. Gerber, Jeffrey R. Infante, Michael S. Gordon, Sarah B. Goldberg, Miguel Martín, Enriqueta Felip, Maria Martinez Garcia, Joan H. Schiller, David R. Spigel, Julie Cordova, Valerie Westcott, Yulei Wang, David S. Shames, YounJeong Choi, Robert Kahn, Randall C. Dere, Divya Samineni, Jian Xu, Kedan Lin, Katie Wood, Stephanie Royer-Joo, Vanessa Lemahieu, Eva Schuth, Anjali Vaze, Daniel Maslyar, Eric W. Humke, Howard A. Burris, III
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (2): 364–372.
DOI: https://doi.org/10.1158/1078-0432.CCR-18-3965
Published: 15 January 2020
View article
PDF
Includes: Supplementary data
Journal Articles

NQO1-dependent, Tumor-selective Radiosensitization of Non–small Cell Lung Cancers

Edward A. Motea, Xiumei Huang, Naveen Singh, Jessica A. Kilgore, Noelle S. Williams, Xian-Jin Xie, David E. Gerber, Muhammad S. Beg, Erik A. Bey, David A. Boothman
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (8): 2601–2609.
DOI: https://doi.org/10.1158/1078-0432.CCR-18-2560
Published: 15 April 2019
View article
PDF
Includes: Supplementary data
Journal Articles

Abstract B32: RADIANCE: An open-label, nonrandomized, prospective biomarker study to assess analytic concordance between noninvasive testing and tissue testing for EGFR T790M mutation detection in patients with non-small cell lung cancer

Hatim Husain, Martin Dietrich, Steven Dubinett, David E. Gerber, Jeffrey Gregg, Michelle Shiller, Howard West, Kim Thai, Alvin Milner, Nabil Chehab, Christina Baik
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (17_Supplement): B32.
DOI: https://doi.org/10.1158/1557-3265.AACRIASLC18-B32
Published: 01 September 2018
View article
Journal Articles

ALCHEMIST Trials: A Golden Opportunity to Transform Outcomes in Early-Stage Non–Small Cell Lung Cancer

Ramaswamy Govindan, Sumithra J. Mandrekar, David E. Gerber, Geoffrey R. Oxnard, Suzanne E. Dahlberg, Jamie Chaft, Shakun Malik, Margaret Mooney, Jeffrey S. Abrams, Pasi A. Jänne, David R. Gandara, Suresh S. Ramalingam, Everett E. Vokes
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (24): 5439–5444.
DOI: https://doi.org/10.1158/1078-0432.CCR-15-0354
Published: 14 December 2015
View article
PDF
Journal Articles

Phase I Safety and Pharmacokinetic Study of Bavituximab, a Chimeric Phosphatidylserine-Targeting Monoclonal Antibody, in Patients with Advanced Solid Tumors

David E. Gerber, Alison T. Stopeck, Lucas Wong, Lee S. Rosen, Philip E. Thorpe, Joseph S. Shan, Nuhad K. Ibrahim
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (21): 6888–6896.
DOI: https://doi.org/10.1158/1078-0432.CCR-11-1074
Published: 31 October 2011
View article
PDF